Document is current
Any future updates will be listed below
-
Authors
Gonçalves, Emanuel
Segura‐Cabrera, Aldo
Pacini, Clare
Picco, Gabriele
Behan, Fiona M
Jaaks, Patricia
Coker, Elizabeth A
van der Meer, Donny
Barthorpe, Andrew
Lightfoot, Howard
Mironenko, Tatiana
Beck, Alexandra
Richardson, Laura
Yang, Wanjuan
Lleshi, Ermira
Hall, James
Tolley, Charlotte https://orcid.org/0000-0002-1119-7983
Hall, Caitlin
Mali, Iman
Thomas, Frances
Morris, James
Leach, Andrew R
Lynch, James T
Sidders, Ben
Crafter, Claire
Iorio, Francesco https://orcid.org/0000-0001-7063-8913
Fawell, Stephen
Garnett, Mathew J https://orcid.org/0000-0002-2618-4237
-
Funding
Funding for this research was provided by:
Wellcome Trust (206194)
AstraZeneca
- License Information
-
More Information
Article History
Received: 18 December 2019
Revised: 14 May 2020
Accepted: 21 May 2020
First Online: 6 July 2020
Conflict of interest
: This work was funded in part by AstraZeneca. M.J.G. receives funding from AstraZeneca. M.J.G., F.I. and A.R.L. receive funding from Open Targets, a public–private initiative involving academia and industry. F.I. performs consulting for the CRUK‐AstraZeneca Functional Genomics Centre. J.T.L., B.S., C.C. and S.F. are current employees of AstraZeneca and hold stock in AstraZeneca.
